Multiple Sclerosis: What Methods are Available for the Assessment of Subclinical Visual System Damage?

References

• Siva A. Asymptomatic MS. Clin Neurol Neurosurg. 2013;115(1):S1–S5. doi:10.1016/j.clineuro.2013.09.012.
   PubMedGoogle Scholar
• Costello F. Vision disturbances in multiple sclerosis. Semin Neurol. 2016;36(2):185–195. doi:10.1055/s-0036-1579692.
   PubMed Web of Science ®Google Scholar
• Cleary PA, Beck RW, Anderson MM Jr, Kenny DJ, Backlund JY, Gilbert PR. Design, methods, and conduct of the optic neuritis treatment trial. Control Clin Trials. 1993;14(2):123–142. doi:10.1016/0197-2456(93)90015-6.
   PubMedGoogle Scholar
• Optic Neuritis Study Group. The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol. 1991;109(12):1673–1678. doi:10.1001/archopht.1991.01080120057025.
   PubMedGoogle Scholar
• Sisto D, Trojano M, Vetrugno M, Trabucco T, Iliceto G, Sborgia C. Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity. Invest Ophthalmol Vis Sci. 2005;46(4):1264–1268. doi:10.1167/iovs.03-1213.
   PubMed Web of Science ®Google Scholar
• Ortiz-Perez S, Andorra M, Sanchez-Dalmau B, et al. Visual field impairment captures disease burden in multiple sclerosis. J Neurol. 2016;263(4):695–702. doi:10.1007/s00415-016-8034-2.
   PubMed Web of Science ®Google Scholar
• Fong KC, Byles DB, Constable PH. Does frequency doubling technology perimetry reliably detect neurological visual field defects? Eye (Lond). 2003;17(3):330–333. doi:10.1038/sj.eye.6700376.
   PubMed Web of Science ®Google Scholar
• Britze J, Frederiksen JL. Optical coherence tomography in multiple sclerosis. Eye (Lond). 2018 May;32(5):884–888. doi:10.1038/s41433-017-0010-2.
   PubMed Web of Science ®Google Scholar
• Alward WL. Frequency doubling technology perimetry for the detection of glaucomatous visual field loss. Am J Ophthalmol. 2000;129(3):376–378. doi:10.1016/s0002-9394(00)00352-4.
   PubMed Web of Science ®Google Scholar
• Corallo G, Cicinelli S, Papadia M, Bandini F, Uccelli A, Calabria G. Conventional perimetry, short-wavelength automated perimetry, frequency-doubling technology, and visual evoked potentials in the assessment of patients with multiple sclerosis. Eur J Ophthalmol. 2005;15(6):730–738. doi:10.1177/112067210501500612.
   PubMed Web of Science ®Google Scholar
• Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol. 2005;58(6):840–846. doi:10.1002/ana.20703.
   PubMed Web of Science ®Google Scholar
• Trip SA, Schlottmann PG, Jones SJ, et al. Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage. 2006;31(1):286–293. doi:10.1016/j.neuroimage.2005.11.051.
   PubMed Web of Science ®Google Scholar
• Karakosta A, Vassilaki M, Plainis S, Elfadl NH, Tsilimbaris M, Moschandreas J. Choice of analytic approach for eye-specific outcomes: One eye or two? Am J Ophthalmol. 2012;153(3):571–579.e1. doi:10.1016/j.ajo.2011.08.032.
   PubMed Web of Science ®Google Scholar
• Keltner JL, Cello KE, Balcer LJ, Calabresi PA, Markowitz CE, Werner JS. Stratus OCT quality control in two multi-centre multiple sclerosis clinical trials. Neuroophthalmology. 2011;35(2):57–64. doi:10.3109/01658107.2011.557760.
   PubMed Web of Science ®Google Scholar
• Salvetat ML, Zeppieri M, Tosoni C, Parisi L, Brusini P. Non-conventional perimetric methods in the detection of early glaucomatous functional damage. Eye (Lond). 2010;24(5):835–842. doi:10.1038/eye.2009.216.
   PubMed Web of Science ®Google Scholar
• Merle H, Olindo S, Donnio A, Richer R, Smadja D, Cabre P. Anatomic and functional correlation of frequency-doubling technology perimetry (FDTP) in multiple sclerosis. Int Ophthalmol. 2011;31(4):263–270. doi:10.1007/s10792-011-9447-7.
   PubMedGoogle Scholar
• Kedar S, Ghate D, Corbett JJ. Visual fields in neuro-ophthalmology. Indian J Ophthalmol. 2011;59(2):103–109. doi:10.4103/0301-4738.77013.
   PubMed Web of Science ®Google Scholar
• Horani A, Frenkel S, Yahalom C, Farber MD, Ticho U, Blumenthal EZ. The learning effect in visual field testing of healthy subjects using frequency doubling technology. J Glaucoma. 2002;11(6):511–516. doi:10.1097/00061198-200212000-00011.
   PubMed Web of Science ®Google Scholar
• Geimer SA. Glaucoma diagnostics. Acta Ophthalmol. 2013;91:1–32. doi:10.1111/aos.12072. Thesis 1.
   PubMedGoogle Scholar
• Dujardin K, Donze AC, Hautecoeur P. Attention impairment in recently diagnosed multiple sclerosis. Eur J Neurol. 1998;5(1):61–66. doi:10.1046/j.1468-1331.1998.510061.x.
   PubMed Web of Science ®Google Scholar
• Warner CV, Syc SB, Stankiewicz AM, et al. The impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trials. PLoS One. 2011;6(8):e22947. doi:10.1371/journal.pone.0022947.
   PubMed Web of Science ®Google Scholar
• Costello F. Evaluating the use of optical coherence tomography in optic neuritis. Mult Scler Int. 2011;2011:148394. doi:10.1155/2011/148394.
   PubMedGoogle Scholar
• Parisi V, Manni G, Spadaro M, et al. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci. 1999;40(11):2520–2527.
   PubMed Web of Science ®Google Scholar
• Trip SA, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol. 2005;58(3):383–391. doi:10.1002/ana.20575.
   PubMed Web of Science ®Google Scholar
• Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology. 2006;113(2):324–332. doi:10.1016/j.ophtha.2005.10.040.
   PubMed Web of Science ®Google Scholar
• Vizzeri G, Weinreb RN, Gonzalez-Garcia AO, et al. Agreement between spectral-domain and time-domain OCT for measuring RNFL thickness. Br J Ophthalmol. 2009;93(6):775–781. doi:10.1136/bjo.2008.150698.
   PubMed Web of Science ®Google Scholar
• Bock M, Brandt AU, Dörr J, et al. Time domain and spectral domain optical coherence tomography in multiple sclerosis: a comparative cross-sectional study. Mult Scler. 2010;16(7):893–896. doi:10.1177/1352458510365156.
   PubMed Web of Science ®Google Scholar
• Klistorner A, Arvind H, Nguyen T, et al. Axonal loss and myelin in early ON loss in postacute optic neuritis. Ann Neurol. 2008;64(3):325–331. doi:10.1002/ana.21474.
   PubMed Web of Science ®Google Scholar
• Toledo J, Sepulcre J, Salinas-Alaman A, et al. Retinal nerve fiber layer atrophy is associated with physical and cognitive disability in multiple sclerosis. Mult Scler. 2008;14(7):906–912. doi:10.1177/1352458508090221.
   PubMed Web of Science ®Google Scholar
• Zaveri MS, Conger A, Salter A, et al. Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis. Arch Neurol. 2008;65(7):924–928. doi:10.1001/archneur.65.7.924.
   PubMedGoogle Scholar
• Talman LS, Bisker ER, Sackel DJ, et al. Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol. 2010;67(6):749–760. doi:10.1002/ana.22005.
   PubMed Web of Science ®Google Scholar
• Cheng H, Laron M, Schiffman JS, Tang RA, Frishman LJ. The relationship between visual field and retinal nerve fiber layer measurements in patients with multiple sclerosis. Invest Ophthalmol Vis Sci. 2007;48(12):5798–5805. doi:10.1167/iovs.07-0738.
   PubMed Web of Science ®Google Scholar
• Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain. 2001;124(Pt 9):1813–1820. doi:10.1093/brain/124.9.1813.
   PubMedGoogle Scholar
• Lassmann H, Suchanek G, Ozawa K. Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis. Ann Neurol. 1994;36(S1):S42–S46. doi:10.1002/ana.410360713.
   PubMedGoogle Scholar
• Costello F, Coupland S, Hodge W, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol. 2006;59(6):963–969. doi:10.1002/ana.20851.
   PubMed Web of Science ®Google Scholar
• Khanifar AA, Parlitsis GJ, Ehrlich JR, et al. Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography. Clin Ophthalmol. 2010. 4:1007–1013. Published 2010 Sep 20. doi:10.2147/opth.s13278.
   PubMedGoogle Scholar
• Costello F, Hodge W, Pan YI, Metz L, Kardon RH. Retinal nerve fiber layer and future risk of multiple sclerosis. Can J Neurol Sci. 2008;35(4):482–487. doi:10.1017/s031716710000915x.
   PubMed Web of Science ®Google Scholar
• Pro MJ, Pons ME, Liebmann JM, et al. Imaging of the optic disc and retinal nerve fiber layer in acute optic neuritis. J Neurol Sci. 2006 1;250(1–2):114–119. doi:10.1016/j.jns.2006.08.012.
   PubMed Web of Science ®Google Scholar
• Sergott RC, Frohman E, Glanzman R, Al-Sabbagh A. OCT in MS Expert Panel. The role of optical coherence tomography in multiple sclerosis: expert panel consensus. J Neurol Sci. 2007 \;263(1–2):3–14. doi:10.1016/j.jns.2007.05.024.
   PubMed Web of Science ®Google Scholar
• Burkholder BM, Osborne B, Loguidice MJ, et al. Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis. Arch Neurol. 2009;66(11):1366–1372. doi:10.1001/archneurol.2009.230.
   PubMedGoogle Scholar
• Saidha S, Syc SB, Ibrahim MA, et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography [published correction appears in brain. Brain. 2011 Dec;134(Pt 2):518–533. doi:10.1093/brain/awq346.
   PubMed Web of Science ®Google Scholar